• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 18, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

What are the costs of continued smoking among patients with cancer?

Bioengineer by Bioengineer
April 5, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: This study was an economic evaluation and it used a model to examine the costs of subsequent cancer treatment associated with continued smoking by patients after their initial cancer treatment failed. The model was developed to consider a host of factors, including expected initial treatment failure rates in nonsmoking patients, how common smoking was, and the cost of cancer treatment after initial treatment failed. The analysis conservatively suggests continued smoking by patients with cancer adds nearly $11,000 per smoking patient in treatment costs after the initial cancer treatment failed. The model has limitations and didn’t quantify the potential benefits of smoking cessation.

Authors: Graham W. Warren, M.D., Ph.D., Medical University of South Carolina, Charleston, South Carolina, and coauthors

(doi: 10.1001/jamanetworkopen.2019.1703)

Editor’s Note: The article contains conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2019.1703?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040519

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Media Contact
Heather Woolwine

[email protected]

Tags: cancerMedicine/HealthSmoking/Tobacco
Share12Tweet8Share2ShareShareShare2

Related Posts

RNA Markers in Forensic Fluid Analysis: Key Insights

November 18, 2025

Genetic Diversity of 10 DIP-STR Markers in US Groups

November 18, 2025

Maternal MSG Exposure Triggers Inflammation, Metabolic Issues

November 18, 2025

Ethnocentrism’s Impact on Advance Care Planning

November 18, 2025
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    211 shares
    Share 84 Tweet 53
  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    201 shares
    Share 80 Tweet 50
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    118 shares
    Share 47 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    89 shares
    Share 36 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Aluminum’s Role in Campo Rupestre Melastomataceae

Outcomes of Single Ventricle Palliation in ccTGA

Dual Telomerase and Mitochondria Inhibition Boosts AML Apoptosis

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.